A comparative study of the effects of two nitric oxide synthase inhibitors and two nitric oxide donors on temporary focal cerebral ischemia in the wistar rat

Journal of Neurosurgery

Volumn 90, Issue 2, 1999, Pages 332-338

  Coert, Bert A ^a   Anderson, Robert E ^a   Meyer, Fredric B ^a  

^a MAYO CLINIC   (United States)

Author keywords

7 nitroindazole; Focal brain ischemia; N(G) nitro L arginine methyl ester; Nitric oxide; Nitric oxide synthase; Rat

Indexed keywords

1 [2 (2 AMINOETHYL) N (2 AMMONIOETHYL)AMINO]DIAZEN 1 IUM 1,2 DIOLATE; 7 NITROINDAZOLE; LINSIDOMINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ISCHEMIA; DRUG EFFECT; DRUG SCREENING; HISTOPATHOLOGY; MALE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0032961726     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.1999.90.2.0332     Document Type: Article

References (53)

1. Ashwal S, Cole DJ, Osborne TN, et al: Dual effects of L-NAME during transient focal cerebral ischemia in spontaneously hypertensive rats. Am J Physiol 267:H276-H284, 1994
2. Ashwal S, Cole DJ, Osborne TN, et al: Low dose L-NAME reduces infarct volume in the rat MCAO/reperfusion model. J Neurosurg Anesthesiol 5:241-249, 1993
3. Beckman JS, Beckman TW, Chen J, et al: Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 87:1620-1624, 1990
4. Berkenboom G, Unger P, Fontaine J: Atherosclerosis and responses of human isolated coronary arteries to endothelium-dependent and -independent vasodilators. J Cardiovasc Pharmacol 14 (Suppl 11):S35-S39, 1989
5. Bohn H, Schönafinger K: Oxygen and oxidation promote the release of nitric oxide from sydnonimines. J Cardiovasc Pharmacol 14 (Suppl 11):S6-S12, 1989
6. Brunton TL: Use of nitrite of amyl in angina pectoris. Lancet 2:97-98, 1867
7. Choi DW: Glutamate neurotoxicity and diseases of the nervous system. Neuron 1:623-634, 1988
8. Coert B, Anderson RE, Meyer FB: The effects of intermittent versus continuous vessel occlusion in a revalidated model of focal cerebral ischemia in the Wistar rat. J Cereb Blood Flow Metab 17 (Suppl 1):S305, 1997 (Abstract)
9. Coyle P: Different susceptibilities to cerebral infarction in spontaneously hypertensive (SHR) and normotensive Sprague-Dawley rats. Stroke 17:520-525, 1986
10. Dalkara T, Yoshida T, Irikura K, et al: Dual role of nitric oxide in focal cerebral ischemia. Neuropharmacology 33: 1447-1452, 1994
11. Dawson VL, Dawson TM: Nitric oxide actions in neurochemistry. Neurochem Int 29:97-110, 1996
12. Dawson VL, Dawson TM. Bartley DA, et al: Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. J Neurosci 13:2651-2661, 1993
13. Dawson VL, Kizushi VM, Huang PL, et al: Resistance to neurotoxicity in cortical cultures from neuronal nitric oxide synthase-deficient mice. J Neurosci 16:2479-2487, 1996
14. Drummond JC, Oh YS, Cole DJ, et al: Phenylephrine-induced hypertension reduces ischemia following middle cerebral artery occlusion in rats. Stroke 20:1538-1544, 1989
15. Dzoljic MR, de Vries R, van Leeuwen R: Sleep and nitric oxide: effects of 7-nitro indazole, inhibitor of brain nitric oxide synthase. Brain Res 718:145-150, 1996
16. Feelisch M: The biochemical pathways of nitric oxide formation from nitrovasodilators: appropriate choice of exogenous NO donors and aspects of preparation and handling of aqueous NO solutions. J Cardiovasc Pharmacol 17 (Suppl 3): S25-S33, 1991
17. Feelisch M, Ostrowski J. Noack E: On the mechanism of NO release from sydnonimines. J Cardiovasc Pharmacol 14 (Suppl 11):S13-S22, 1989
18. Foucher-Lavergne A, Kolsky H, Spreux-Varoquaux O, et al: Hemodynamics, tolerability, and pharmacokinetics of linsidomine (SIN-1) infusion during the acute phase of uncomplicated myocardial infarction. J Cardiovasc Pharmacol 22: 779-784, 1993
19. Hamada J, Greenberg JH, Croul S, et al: Effects of central inhibition of nitric oxide synthase on focal cerebral ischemia in rats. J Cereb Blood Flow Metab 15:779-786, 1995
20. Hara H, Huang PL, Panahian N, et al: Reduced brain edema and infarction volume in mice lacking the neuronal isoform of nitric oxide synthase after transient MCA occlusion. J Cereb Blood Flow Metab 16:605-611, 1996
21. 2+/calmodulin-dependent formation of hydrogen peroxide by brain nitric oxide synthase. Biochem J 281:627-630, 1992
22. Hogg N, Darley-Usmar VM, Wilson MT, et al: Production of hydroxyl radicals from the simultaneous generation of superoxide and nitric oxide. Biochem J 281:419-424, 1992
23. Hrabie JA, Klose JR, Wink DA, et al: New nitric oxide-releasing zwitterions derived from polyamines. J Org Chem 58: 1472-1476, 1993
24. Iadecola C: Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci 20:132-139, 1997
25. Iadecola C, Pelligrino DA, Moskowitz MA, et al: Nitric oxide synthase inhibition and cerebrovascular regulation. J Cereb Blood Flow Metab 14:175-192, 1994
26. Iadecola C, Xu X, Zhang F, et al: Prolonged inhibition of brain nitric oxide synthase by short-term systemic administration of nitro-L-arginine methyl ester. Neurochem Res 19:501-505, 1994
27. Kader A, Frazzini VI, Solomon RA, et al: Nitric oxide production during focal cerebral ischemia in rats. Stroke 24: 1709-1716, 1993
28. Kelly PA, Ritchie IM, Arbuthnott GW: Inhibition of neuronal nitric oxide synthase by 7-nitroindazole: effects upon local cerebral blood flow and glucose use in the rat. J Cereb Blood Flow Metab 15:766-773, 1995
29. Keim M, Feelisch M, Spahr R, et al: Quantitative and kinetic characterization of nitric oxide and EDRF released from cultured endothelial cells. Biochem Biophys Res Commun 154: 236-244, 1988
30. Kuluz JW, Prado RJ, Dietrich WD, et al: The effect of nitric oxide synthase inhibition on infarct volume after reversible focal cerebral ischemia in conscious rats. Stroke 24:2023-2029, 1993
31. Lei SZ, Pan ZH, Aggarwal SK, et al: Effect of nitric oxide production on the redox modulatory site of the NMDA receptor-channel complex. Neuron 8:1087-1099, 1992
32. MacKenzie GM, Rose S, Bland-Ward PA, et al: Time course of inhibition of brain nitric oxide synthase by 7-nitro indazole. Neuroreport 5:1993-1996, 1994
33. Macrae IM, Dawson DA, Norrie JD, et al: Inhibition of nitric oxide synthesis: effects on cerebral blood flow and glucose utilisation in the rat. J Cereb Blood Flow Metab 13:985-992, 1993
34. Maiese K, Pek L, Berger SB, et al: Reduction in focal cerebral ischemia by agents acting at imidazole receptors. J Cereb Blood Flow Metab 12:53-63, 1992
35. Malinski T, Bailey F, Zhang ZG, et al: Nitric oxide measured by a porphyrinic microsensor in rat brain after transient middle cerebral artery occlusion. J Cereb Blood Flow Metab 13: 355-358, 1993
36. Margaill I, Parmentier S, Callebert J, et al: Short therapeutic window for MK-801 in transient focal cerebral ischemia in normotensive rats. J Cereb Blood Flow Metab 16:107-113, 1996
37. Moncada S, Palmer RMJ, Higgs EA: Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109-142, 1991
38. Moore PK, Babbedge RC, Wallace P, et al: 7-Nitro indazole, an inhibitor of nitric oxide synthase, exhibits anti-nociceptive activity in the mouse without increasing blood pressure. Br J Pharmacol 108:296-297, 1993
39. Morikawa E, Moskowitz MA, Huang Z, et al: L-arginine infusion promotes nitric oxide-dependent vasodilation, increases regional cerebral blood flow, and reduces infarction volume in the rat. Stroke 25:429-435, 1994
40. Ngai AC, Meno JR, Winn HR: L-NNA suppresses cerebrovascular response and evoked potentials during somatosensory stimulation in rats. Am J Physiol 269:H1803-H1810, 1995
41. Noack E, Feelisch M: Molecular aspects underlying the vasodilator action of molsidomine. J Cardiovasc Pharmacol 14 (Suppl 11):Sl-S5, 1989
42. G-L-arginine methyl esther, dose dependently reduce the threshold for isoflurane anesthesia. Anesthesiology 85:1111-1119, 1996
43. Rothman SM, Olney JW: Excitotoxicity and the NMDA receptor - still lethal after eight years. Trends Neurosci 18:57-58, 1995
44. Rothman SM, Olney JW: Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann Neurol 19:105-111, 1986
45. Samdani AF, Dawson TM, Dawson VL: Nitric oxide synthase in models of focal ischemia. Stroke 28:1283-1288, 1997
46. Shukla A, Dikshit M, Srimal RC: Nitric oxide-dependent blood-brain barrier permeability alteration in the rat brain. Experientia 52:136-140, 1996
47. Tamura A, Graham DI, McCulloch J, et al: Focal cerebral ischaemia in the rat: 1. Description of technique and early neuropathological consequences following middle cerebral artery occlusion. J Cereb Blood Flow Metab 1:53-60, 1981
48. Traystman RJ, Moore LE, Helfaer MA, et al: Nitro-L-arginine analogues. Dose-and time-related nitric oxide synthase inhibition in brain. Stroke 26:864-869, 1995
49. Villarete LH, Remick DG: Nitric oxide regulation of IL-8 expression in human endothelial cells. Biochem Biophys Res Commun 211:671-676, 1995
50. Yoshida T, Limmroth V, Irikura K, et al: The NOS inhibitor, 7-nitroindazole, decreases focal infarct volume but not the response to topical acetylcholine in pial vessels. J Cereb Blood Flow Metab 14:924-929, 1994
51. Zagvazdin Y, Sancesario G, Wang YX, et al: Evidence from its cardiovascular effects that 7-nitroindazole may inhibit endothelial nitric oxide synthase in vivo. Eur J Pharmacol 303:61-69, 1996
52. Zhang F, Iadecola C: Nitroprusside improves blood flow and reduces brain damage after focal ischemia. Neuroreport 4: 559-562, 1993
53. Zhang F, White JG, Iadecola C: Nitric oxide donors increase blood flow and reduce brain damage in focal ischemia: evidence that nitric oxide is beneficial in the early stages of cerebral ischemia. J Cereb Blood Flow Metab 14:217-226, 1994